Immunohistochemical demonstration of oestrogen and progesterone receptors in paraffin sections of breast carcinoma

Current Diagnostic Pathology

Volumn 4, Issue 3, 1997, Pages 176-180

  Shousha, Sami ^a   Peston, David ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001354842     PISSN: 09686053     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-6053(05)80006-7     Document Type: Article

References (34)

1. Sacks N P M, Baum M. Primary management of carcinoma of the breast. Lancet 1993; 342: 1402-1408.
2. Greene G L, Nolan C, Engler J P, Jensen E V. Monoclonal antibodies to human estrogen receptors. Proc Natl Acad Sei USA 1980; 77:5115-5119.
3. King W J, Greene G L. Monoclonal antibodies localize estrogen receptor in the nuclei of target cells. Nature 1984; 307: 745-746.
4. McCarty K S Jr, Miller L S, Cox E B, Konrath J, McCarty K S Sr. Estrogen receptor analyses: correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med 1985; 109: 716-721.
5. Pertschuk L P, Eisenberg K B, Carter A C, Feldman J G. Immunohistologic localization of estrogen receptors in breast cancer with monoclonal antibodies: correlation with biochemistry and clinical endocrine response. Cancer 1985; 55: 1513-1518.
6. Shintaku I P, Said J W. Detection of estrogen receptors with monoclonal antibodies in routinely processed formalin-fixed paraffin sections of breast carcinoma. Use of DNase pretreatment to enhance sensitivity of the reaction. Am J Clin Pathol 1987; 87: 161-167.
7. DeRosa C M, Ozzello L, Greene G L, Habif D V. Immunostaining of estrogen receptor in paraffin sections of breast carcinomas using monoclonal antibody D75P3y: Effects of fixation. Am J Surg Pathol 1987; 11: 943-950.
8. Teasdale J, Jackson P, Holgate C S, Cowen P N. Identification of oestrogen receptors in cells of paraffin-processed breast cancers by IGSS. Histochemistry 1987; 87: 185-187.
9. Cheng L, Binder S W, Fu Y S, Lewin K J. Demonstration of estrogen receptors by monoclonal antibody in formalin-fixed breast tumours. Lab Invest 1988; 58: 346-353.
10. Hiort O, Kwan P W L, DeLellis R A. Immunohistochemistry of estrogen receptor protein in paraffin sections. Effects of enzymatic pretreatment and cobalt chloride intensification. Am J Clin Pathol 1988; 90: 559-563.
11. Al Saati T, Clamens S, Cohen-Knafo E et al. Production of monoclonal antibodies to human estrogen-receptor protein (ER) using recombinant ER (RER). Int J Cancer 1993; 55: 651-654.
12. Hendricks J B, Wilkinson E J. Comparison of two antibodies for evaluation of estrogen receptors in paraffin-embedded tumors. Mod Pathol 1993; 6: 765-770.
13. Sannino P, Shousha S. Demonstration of oestrogen receptors in paraffin wax sections of breast carcinoma using the monoclonal antibody 1D5 and microwave oven processing. J Clin Pathol 1994; 47: 90-92.
14. Jotti G S, Johnston S R D, Salter J, Detre S, Dowsett M. Comparison of new immunohistochemical assay for estrogen receptor in paraffin wax embedded breast carcinoma tissue with quantitative enzyme immunoassay. J Clin Pathol 1994; 47: 900-905.
15. Goulding H, Finder S, Cannon P et al. A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples. Hum Pathol 1995; 26: 291-294.
16. Zidan A, Christie Brown J S, Peston D, Shousha S. Oestrogen and progesterone receptor assessment in core biopsy specimens of breast carcinoma. J Clin Pathol 1997; 50: 27-29.
17. Pertschuk L P, Feldman J G, Kirn Y-D, Braithwaite L, Schneider F, Braverman A S, Axiotis C. Estrogen receptor immunocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Spv in frozen sections or cytosol-based ligand-binding assays. Cancer 1996; 77: 2514-2519.
18. Perrot-Applanat M, Groyer-Picard M-T, Lorenzo F et al. Immunocytochemical study with monoclonal antibodies to progesterone receptor in human breast tumors. Cancer Res 1987; 47:2652-2661.
19. Press M F, Greene G L. Localization of progesterone receptor with monoclonal antibodies to the human progestin receptor. Endocrinology 1988; 122: 1165-1175.
20. Pertschuk L P, Feldman J G, Eisenberg K B et al. Immunocytochemical detection of progesterone receptor in breast cancer with monoclonal antibody. Relation to biochemical assay, disease-free survival, and clinical endocrine response. Cancer 1988; 62: 342-349.
21. Giri D D, Goepel J R, Rogers K, Underwood J C E. Immunohistological demonstration of progesterone receptor in breast carcinoma: correlation with radioligand binding assays and oestrogen receptor immunohistology. J Clin Pathol 1988; 41:444 417.
22. Perrot-Applanat M, Groyer-Picard M-T, Vu Hai M T, Pallud C, Spyratos F, Milgrom E. Immunocytochemical staining of progesterone receptor in paraffin sections of human breast cancers. Am J Pathol 1989; 135:457-468.
23. Soomro S, Shousha S. Demonstration of progesterone receptors in paraffin wax sections of breast carcinoma. J Clin Pathol 1990; 43: 671-674.
24. Masood S, Dee S, Goldstein J D. Immunocytochemical analysis of progesterone receptors in breast cancer. Am J Clin Pathol 1991; 96: 59-63.
25. Allred D C. Should immunohistochemical examination replace biochemical hormone receptor assays in breast cancer? Am J Clin Pathol 1993; 99: 1-3.
26. Christie Brown J S, Peston D, Shousha S. Effect of delayed and prolonged fixation on mitotic index, Ki67 and hormone receptor immunocytochemistry in breast carcinomas. J Pathol 1996; 179(Suppl): ISA.
27. Jensen V, Ladekarl M. Immunohistochemical quantitation of oestrogen receptors and proliferative activity in oestrogen receptor positive breast cancer. J Clin Pathol 1995; 48:429-432.
28. Muensch H, Maslow W C. Interference of OCT embedding compound with hormone receptor assays. Am J Clin Pathol 1984; 82: 98-92.
29. Detre S, Saccani Jotti G, Dowsett M. A 'quickscore' method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. J Clin Pathol 1995; 48: 876-878.
30. Esteban J M, Ahn C, Mehta P, Battifora H. Biologic significance of quantitative estrogen receptor immunohistochemical assay by image analysis in breast cancer. Am J Clin Pathol 1994; 102: 158-162.
31. Van Agthoven T, Timmermans M, Dorssers L C J, HenzenLogmans S C. Expression of estrogen, progesterone and epidermal growth factor receptors in primary and metastatic breast cancer. Int J Cancer 1995; 63: 790-793.
32. Kaufmann O, Deidesheimer T, Muehlenberg M, Deicke P, Dietel M. Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary site. Histopathology 1996; 29: 233-240.
33. Masood S, Lerch V, Rodenroth N. Application of automated immunohistochemistry for assessing estrogen and progesterone receptors in patients with breast cancer. J Histotechnol 1989; 12:265-269.
34. Taylor C R. Paraffin section immunocytochemistry for estrogen receptor. Cancer 1996; 77: 2419-2422.